12:30 | 06.11.2008
Burcon Engages Financial Advisor
VANCOUVER, Canada, November 6 /PRNewswire/ — Burcon NutraScience Corporation (TSX-V: BU) announces today the
appointment of BMO Capital Markets to act as exclusive financial advisor to
Burcon in connection with a process to identify and pursue strategic
alternatives for the commercialization of its innovative food technology.
In engaging BMO Capital Markets, Burcon is initiating an extensive review
of alternative strategies for maximizing shareholder value arising from
Burcon’s intellectual property portfolio including the recently announced soy
protein isolate technology and CLARISOY(TM).
Mr. Johann F. Tergesen, Burcon’s President and C.O.O. noted “The goal of
this engagement is simple: maximizing the value of Burcon and Burcon’s
intellectual property portfolio. We have been working with BMO Capital
Markets and their food and agribusiness teams in Toronto and Chicago, who
understand the potential of our company and have formidable credentials in
the agribusiness and food industries. We have many opportunities in front of
us and we are excited to have BMO Capital Markets helping us to chart a
course of action.”
About Burcon NutraScience
Burcon is a research and development company developing a portfolio of
composition, application, and process patents around its plant protein
extraction and purification technology. The goal of Burcon’s research is to
develop its patented process to utilize inexpensive oilseed meals for the
production of purified plant proteins that exhibit valuable nutritional,
functional or nutraceutical profiles. Burcon, in conjunction with Archer
Daniels Midland, is currently focusing its efforts on developing the world’s
first commercial canola proteins, Puratein(R) and Supertein(TM). Canola,
recognized for its nutritional qualities, is the second-largest oilseed crop
in the world after soybeans. Burcon’s goal is to develop Puratein(R) and
Supertein(TM) to participate with soy, dairy, and egg proteins in the
expanding multi-billion-dollar protein ingredient market, with potential uses
in prepared foods, nutritional supplements, and personal care products.
ON BEHALF OF THE BOARD OF DIRECTORS
“Johann F. Tergesen”
Johann F. Tergesen
President & Chief Operating Officer
The TSX Venture Exchange has not reviewed and does not accept
responsibility for the adequacy of the content of the information contained
herein. This press release contains forward-looking statements that involve
risks and uncertainties. These forward-looking statements relate to, among
other things, plans and timing for the introduction or enhancement of our
products, statements about future market conditions, supply and demand
conditions, and other expectations, intentions and plans contained in this
press release that are not historical fact. Our expectations regarding the
prospect for future success depend upon our ability to develop and sell
products, which we do not produce today and cannot be sold without further
research and development. When used in this press release, the words “goal,”
“intend,” “believes” and “potential” and similar expressions, generally
identify forward-looking statements. These statements reflect our current
expectations. They are subject to a number of risks and uncertainties. In
light of the many risks and uncertainties surrounding the development of a
source of protein from canola meal, you should understand that we cannot
assure you that the forward looking statements contained in this press
release will be realized.
For further information: Jade Cheng, Chief Financial Officer, Burcon
NutraScience Corporation, +1-604-733-0896, 888-408-7960 toll-free,
jcheng@burcon.ca, http://www.burcon.ca; AXINO AG, Sven Olsson, Investor
Relations Europe, Konigstrasse 26 70173 Stuttgart, Germany, Tel.
+49-711-25-35-92-30, Fax +49-711-25-35-92-33, olsson@axino.de,
http://www.burcon.net/
Burcon NutraScience Corporation
For further information: Jade Cheng, Chief Financial Officer, Burcon NutraScience Corporation, +1-604-733-0896, 888-408-7960 toll-free, jcheng@burcon.ca; AXINO AG, Sven Olsson, Investor Relations Europe, Konigstrasse 26 70173 Stuttgart, Germany, Tel. +49-711-25-35-92-30, Fax +49-711-25-35-92-33, olsson@axino.de
|
